BlackRock iShares Nasdaq Us Btec UCITS 

$8.76
47
+$0.04+0.46% Today

Statistics

Day High
8.82
Day Low
8.7
52W High
8.8
52W Low
5.52
Volume
5,909.95
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.35%
Dividend
0.03

Upcoming

Expense Ratio

0.35%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.35%Dividend Yield
Dec 25
$0.01
Jun 25
$0.02
Dec 24
$0.01
Jun 24
$0.02
Dec 23
$0.01
10Y Growth
N/A
5Y Growth
12.37%
3Y Growth
6.89%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BTEE.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, directly competes by tracking a similar biotechnology index.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, offers exposure to the biotech sector, competing for similar investor interest.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, competes by investing in a portfolio of biotech companies.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, targets the biotech industry, similar to BTEE.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genome companies.
Principal Healthcare Innovators
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF, focuses on healthcare innovation, including biotech, competing for the same niche.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, targets small- and mid-cap biotech companies, offering a similar investment focus.
Virtus Biotech
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF, competes by investing in biotech companies with one or more products in Phase III clinical trials.
Virtus Biotech Clinical Trials
BBC
Mkt Cap0
Virtus LifeSci Biotech Clinical Trials ETF, focuses on companies in clinical trials, offering a unique angle within the biotech sector.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF, competes by focusing on the genomics and biotech sectors, appealing to similar investors.

Holdings

Regions

Sectors

About

NA
Show more...
CEO
Country
United Kingdom
ISIN
IE00BDZVHG35

Listings

0 Comments

Share your thoughts

FAQ

What is BlackRock iShares Nasdaq Us Btec UCITS stock price today?
The current price of BTEE.LSE is $8.76 USD — it has increased by +0.46% in the past 24 hours. Watch BlackRock iShares Nasdaq Us Btec UCITS stock price performance more closely on the chart.
What is BlackRock iShares Nasdaq Us Btec UCITS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange BlackRock iShares Nasdaq Us Btec UCITS stocks are traded under the ticker BTEE.LSE.
Is BlackRock iShares Nasdaq Us Btec UCITS stock price growing?
BTEE.LSE stock has risen by +2.01% compared to the previous week, the month change is a +5.1% rise, over the last year BlackRock iShares Nasdaq Us Btec UCITS has showed a +51.8% increase.
Does BlackRock iShares Nasdaq Us Btec UCITS pay dividends?
Yes, BTEE.LSE dividends are paid semi-annual. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 0.35%.
In which sector is BlackRock iShares Nasdaq Us Btec UCITS located?
BlackRock iShares Nasdaq Us Btec UCITS operates in the Other sector.
When did BlackRock iShares Nasdaq Us Btec UCITS complete a stock split?
BlackRock iShares Nasdaq Us Btec UCITS has not had any recent stock splits.